Related Experiment Video
Updated: Sep 9, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
An Interventional Radiology Method for In Situ Assessments of Cancer Drug Response: Preclinical Development,
Sharath K Bhagavatula1, Ryan Reichert2, Sebastian W Ahn1
1Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Ave, BL 429, Boston, MA 02115.
Abstract:
Purpose To evaluate the technical feasibility and safety of a nonsurgical interventional method for placement and retrieval of implantable microdevices (IMDs) in a rabbit tumor model. Materials and Methods This prospective preclinical feasibility and safety study was conducted from March 2022 to October 2024. Interventional IMD placement and retrieval were performed in 12 rabbits with single hindlimb VX2 tumors. Four or five IMDs were placed per animal. Each IMD delivered microdose quantities of three drugs (doxorubicin, topotecan, sunitinib) into 18 spatially distinct microscopic tumor regions over 24-48 hours. An over-the-wire biopsy procedure was used to extract the IMDs and surrounding tumor. Technical success was defined per animal as retrieval of at least one tumor region containing each of the three drugs. Overall region-level retrieval success rate was calculated as the overall percentage of drug-exposed regions retrieved successfully. Safety was determined by monitoring animals for adverse events. Procedure durations were assessed to inform clinical translation. Statistical analysis included calculation of binomial 95% CIs for success rates and summary statistics (mean ± SD) for region yield and procedure times. Results Twelve rabbits received 52 IMDs (mean, 4.3 ± 0.5 per animal) generating 936 drug-exposure sites. Technical success was 100% (12 of 12; 95% CI: 73.5, 100). Mean per animal retrieval was 50.7 regions ± 11.4 (range, 33-69), with an overall region-level success rate of 65% (608 of 936; 95% CI: 62, 68). No Common Terminology Criteria for Adverse Events grade 2 (moderate) or higher adverse events were observed. In two animals, IMDs dislodged from the guidewire and were retained in the tumor; no symptoms developed, and no additional intervention was required (grade 1). Implantation procedure duration was 30.3 minutes ± 5.3 and retrieval procedure duration was 49.1 minutes ± 6.3. Conclusion Interventional IMD placement and retrieval in a rabbit soft tissue tumor model was technically feasible and safe. This approach demonstrated the capacity to recover multiple drug-exposed regions for in situ assessment of local drug effects. Keywords: Implantable Microdevice, Personalized Treatment, Percutaneous Biopsy, Phase 0 Trials, Microdosing, Interventional Radiology Supplemental material is available for this article. © RSNA, 2025.
More Related Videos
Related Concept Videos
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...

